课题基金 / 基金详情

Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles

Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
批准号:
10529270
负责人:
Roger Keith Reeves
金额:
$40.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-01 至 2024-11-30

项目摘要

项目成果

Roger Keith Reeves的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite efficient suppression of plasma viremia in HIV-infected patients on cART, replication competent virus is still recoverable from a variety of anatomic sites. A major reservoir of HIV and pathogenic SIV infection in rhesus macaques (RM) are lymph node follicles (via replication in TFH cells and viral trapping by FDC) that generally prohibit access to cytotoxic CD8+ T cells. Interestingly, nonpathogenic SIV infection of African green monkeys (AGM) exhibits high viral loads in blood and the gut mucosae, but lacks virus in lymphoid follicles. Natural killer (NK) cells provide rapid early responses to HIV/SIV infections and contribute substantially to disease modulation and vaccine protection, but the underlying mechanisms for NK cell surveillance and modulation of HIV/SIV reservoirs is unclear. Our recent research indicates that SIV can be effectively cleared from lymphoid follicles in nonpathogenic AGM but not pathogenic RM hosts and is dependent on an IL-15- dependent redistribution of NK cells to lymph node follicles and increased CXCR5 expression on AGM NK (Huot et al. Nature Medicine 2017). In this innovative proposal we will utilize three SIV-infected nonhuman primate models to test the central hypothesis that NK cells critically contribute to the reduction of SIV reservoirs. Specifically we will: (1) Determine mechanisms associated with NK cell-mediated control of SIV reservoirs; and (2) Determine mechanisms associated with NK cell failure to control SIV reservoirs in lymph nodes and associated pathogenesis. Application of these data could contribute substantially to future HIV/SIV vaccines, immunotherapeutics, or reservoir purging strategies that harness the potent antiviral potential of NK cells.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/vaccines9090958
发表时间: 2021-08-27
期刊: Vaccines
影响因子: 7.8
作者: [Terrade G, Huot N, Petitdemange C, Lazzerini M, Orta Resendiz A, Jacquelin B, Müller-Trutwin M]
通讯作者: Müller-Trutwin M
DOI: 10.3389/fimmu.2020.02134
发表时间: 2020
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Huot N, Rascle P, Petitdemange C, Contreras V, Palgen JL, Stahl-Hennig C, Le Grand R, Beignon AS, Jacquelin B, Müller-Trutwin M]
通讯作者: Müller-Trutwin M
DOI: 10.1038/s41590-023-01661-4
发表时间: 2023-12
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者: [Huot, Nicolas, Planchais, Cyril, Rosenbaum, Pierre, Contreras, Vanessa, Jacquelin, Beatrice, Petitdemange, Caroline, Lazzerini, Marie, Beaumont, Emma, Orta-Resendiz, Aurelio, Rey, Felix A., Reeves, R. Keith, Le Grand, Roger, Mouquet, Hugo, Mueller-Trutwin, Michaela]
通讯作者: Mueller-Trutwin, Michaela
DOI: 10.1016/j.isci.2021.103109
发表时间: 2021-10-22
期刊: iScience
影响因子: 5.8
作者: [Rascle P, Jacquelin B, Petitdemange C, Contreras V, Planchais C, Lazzerini M, Dereuddre-Bosquet N, Le Grand R, Mouquet H, Huot N, Müller-Trutwin M]
通讯作者: Müller-Trutwin M
6
    Microbial and innate immune mechanisms of oral inflammation during SIV infection
    • 批准号:
      10408915
    • 项目类别:
    • 资助金额:
      $20.93万
    • 财政年份:
      2021
    • 负责人:
      Roger Keith Reeves
    • 依托单位:
    NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
    • 批准号:
      10319735
    • 项目类别:
    • 资助金额:
      $40.25万
    • 财政年份:
      2021
    • 负责人:
      Roger Keith Reeves
    • 依托单位:
    Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
    • 批准号:
      10408913
    • 项目类别:
    • 资助金额:
      $69.76万
    • 财政年份:
      2021
    • 负责人:
      Roger Keith Reeves
    • 依托单位:
    NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
    • 批准号:
      10458737
    • 项目类别:
    • 资助金额:
      $40.25万
    • 财政年份:
      2021
    • 负责人:
      Roger Keith Reeves
    • 依托单位:
    海外基金